Abstract
Low-grade chronic systemic inflammation is often associated with chronic non-communicable diseases, and its most frequently used marker, the C-reactive protein (CRP), has become an identifier of such diseases as well as an independent predictor for cardiovascular disorders and mortality. CRP is produced in response to pro-inflammatory signaling and to individual and behavioral factors, leading to pathological states. The aim of this study was to rank the predicting factors of high CRP concentrations in free-living adults from a community-based sample. We evaluated 522 adults (40–84 years old; 381 women) for anthropometric characteristics, dietary intake, clinical and physical tests, and blood analysis. Subjects were assigned to groups, according to CRP concentrations, as normal CRP (G1; <3.0 mg/L; n = 269), high CRP (G2; 3.0–6.0 mg/L; n = 139), and very high CRP (G3; >6.0 mg/dL; n = 116). Statistical comparison between groups used one-way ANOVA or Kruskal–Wallis tests, and prediction of altered values in increasing CRP was evaluated by proportional hazard models (odds ratio). CRP distribution was influenced by gender, body mass index, body and abdominal fatness, blood leukocytes, and neutrophil counts. The higher CRP group was discriminated by the above variables in addition to lower VO2max, serum metabolic syndrome components (triglycerides, glucose, and HDL cholesterol), higher insulin, homeostasis assessment of insulin resistance, uric acid, gamma-GT, and homocysteine. After adjustments, only fatness, blood leukocytes, and hyperglycemia remained as independent predictors for increased serum CRP concentrations. Intervention procedures to treat low-grade chronic inflammation in overweight women would mainly focus on restoring muscle mass and functions in addition to an antioxidant-rich diet.
Similar content being viewed by others
Abbreviations
- CRP:
-
C-Reactive protein
- nCRP:
-
Normal C-reactive protein concentration group
- hCRP:
-
High C-reactive protein concentration group
- vhCRP:
-
Very high C-reactive protein concentration group
- AIT:
-
Anti-inflammatory treatment
- CNCD:
-
Chronic non-communicable diseases
- MetS:
-
Metabolic syndrome
- T2DM:
-
Type-two diabetes mellitus
- NCEP-ATPIII:
-
National Cholesterol Education Program–Adult Treatment Panel III
- BP:
-
Blood pressure
- BMI:
-
Body mass index
- MMI:
-
Muscle mass index
- WC:
-
Waist circumference
- %BF:
-
Percentage of body fat
- HEI:
-
Healthy eating index
- HGS:
-
Handgrip strength
- VO2max :
-
Maximum oxygen uptake
- FFA:
-
Free fat acids
- NASH:
-
Non-alcoholic steatohepatitis
- HOMA-IR:
-
Homeostasis assessment of insulin resistance
- SCN− :
-
Salivary thiocyanate
- Hcy:
-
Homocysteine
- MDA:
-
Malonyldialdehyde
- IL-6:
-
Interleukin 6
- TNF-α:
-
Tumor necrosis factor alpha
- NF-κB:
-
Nuclear factor kappa B
- JNK:
-
c-Jun amino-terminal kinase
- MAPK:
-
Mitogen-activated protein kinase
- PGC1α:
-
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha
- AGEs:
-
Advanced glycation end
REFERENCES
Heinrich, P.C., J.V. Castell, and T. Andus. 1990. Interleukin-6 and the acute phase response. Biochemical Journal 265: 621–636.
Povoa, P., E. Almeida, P. Moreira, A. Fernandes, R. Mealha, A. Aragao, and H. Sabino. 1998. C-Reactive protein as an indicator of sepsis. Intensive Care Medicine 24: 1052–1056.
Neumaier, M., G. Metak, and M.A. Scherer. 2006. C-Reactive protein as a parameter of surgical trauma: CRP response after different types of surgery in 349 hip fractures. Acta Orthopaedica 77: 788–790.
Bassuk, S.S., N. Rifai, and P.M. Ridker. 2004. High-sensitivity C-reactive protein: clinical importance. Current Problems in Cardiology 29: 439–493.
Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature 454: 428–435.
Bensinger, S.J., and P. Tontonoz. 2008. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454: 470–477.
Belfki, H., S. Ben Ali, S. Bougatef, D. Ben Ahmed, N. Haddad, A. Jmal, M. Abdennebi, and H. Ben Romdhane. 2012. Association between C-reactive protein and type 2 diabetes in a Tunisian population. Inflammation 35: 684–689.
Ridker, P.M. 2008. High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care. Clinical Chemistry 54: 234–237.
Devaraj, S., S.K. Venugopal, U. Singh, and I. Jialal. 2005. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes 54: 85–91.
Puglisi, M.J., and M.L. Fernandez. 2008. Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. Journal of Nutrition 138: 2293–2296.
Hotamisligil, G.S. 2006. Inflammation and metabolic disorders. Nature 444: 860–867.
Janssen, I., S.B. Heymsfield, R.N. Baumgartner, and R. Ross. 2000. Estimation of skeletal muscle mass by bioelectrical impedance analysis. Journal of Applied Physiology 89: 465–471.
LA Philippi, S.T., A.T.R. Cruz, and L.C. Ribeiro. 1999. Adapted food pyramid: a guide for a right food choice. Revista de Nutrição 12: 16.
Mota, J.F., A.E.M. Rinaldi, A.F. Pereira, N. Maestá, M.M. Scarpin, and R.C. Burini. 2008. Adaptation of the healthy eating index to the food guide of the Brazilian population. Revista de Nutrição 21: 8.
Balke, B., and R.W. Ware. 1959. An experimental study of physical fitness of air force personnel. United States Armed Forces Medical Journal 10: 675–688.
Galanti, L.M. 1997. Specificity of salivary thiocyanate as marker of cigarette smoking is not affected by alimentary sources. Clinical Chemistry 43: 184–185.
Ubbink, J.B., W.J. Hayward Vermaak, and S. Bissbort. 1991. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. Journal of Chromatography 565: 441–446.
Nielsen, F., B.B. Mikkelsen, J.B. Nielsen, H.R. Andersen, and P. Grandjean. 1997. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clinical Chemistry 43: 1209–1214.
Grundy, S.M., J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., et al. 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735–2752.
Nicklas, B.J., and T.E. Brinkley. 2009. Exercise training as a treatment for chronic inflammation in the elderly. Exercise and Sport Sciences Reviews 37: 165–170.
Thorand, B., J. Baumert, A. Doring, C. Herder, H. Kolb, W. Rathmann, G. Giani, and W. Koenig. 2006. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184: 216–224.
Kupelian, V., G.R. Chiu, A.B. Araujo, R.E. Williams, R.V. Clark, and J.B. McKinlay. 2010. Association of sex hormones and C-reactive protein levels in men. Clinical Endocrinology 72: 527–533.
Albert, M.A., R.J. Glynn, J. Buring, and P.M. Ridker. 2004. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). The American Journal of Cardiology 93: 1238–1242.
Lakoski, S.G., M. Cushman, M. Criqui, T. Rundek, R.S. Blumenthal, R.B. D'Agostino Jr., and D.M. Herrington. 2006. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. American Heart Journal 152: 593–598.
Povoa, P., A.M. Teixeira-Pinto, and A.H. Carneiro. 2011. C-Reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Critical Care 15: R169.
Rogowski, O., I. Shapira, O.K. Bassat, T. Chundadze, T. Finn, S. Berliner, and A. Steinvil. 2010. Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study. Journal of Inflammation (London) 7: 35.
Maki, K.C., T.M. Rains, M. Bell, M.S. Reeves, M.V. Farmer, and K. Yasunaga. 2011. Fat mass, abdominal fat distribution, and C-reactive protein concentrations in overweight and obese men and women. Metab Syndre Relat Disord 9: 291–6.
Lin, C.C., S.L. Kardia, C.I. Li, C.S. Liu, M.M. Lai, W.Y. Lin, P.C. Chang, Y.D. Lee, C.C. Chen, C.H. Lin, et al. 2010. The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population. BMC Public Health 10: 579.
Zuliani, G., S. Volpato, M. Galvani, A. Ble, S. Bandinelli, A.M. Corsi, F. Lauretani, M. Maggio, J.M. Guralnik, R. Fellin, and L. Ferrucci. 2009. Elevated C-reactive protein levels and metabolic syndrome in the elderly: the role of central obesity data from the InChianti study. Atherosclerosis 203: 626–632.
Tarantino, G., A. Colao, D. Capone, P. Conca, M. Tarantino, E. Grimaldi, D. Chianese, C. Finelli, F. Contaldo, F. Scopacasa, and S. Savastano. 2011. Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. Journal of Biological Regulators and Homeostatic Agents 25: 47–56.
Esposito, K., F. Nappo, R. Marfella, G. Giugliano, F. Giugliano, M. Ciotola, L. Quagliaro, A. Ceriello, and D. Giugliano. 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106: 2067–2072.
Mota, J.F., F. Moreto, W.L. Medina, E.C. Leite Pereira, and R.C. Burini. 2011. Nutritional and metabolic risk factors for insulin resistance in adults. International Journal of Nutrition and Metabolism 7: 3.
Pradhan, A.D., J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker. 2001. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327–334.
Kado, S., T. Nagase, and N. Nagata. 1999. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetologica 36: 67–72.
Shikano, M., H. Sobajima, H. Yoshikawa, T. Toba, H. Kushimoto, H. Katsumata, M. Tomita, and S. Kawashima. 2000. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 85: 81–85.
Mohamed-Ali, V., S. Goodrick, A. Rawesh, D.R. Katz, J.M. Miles, J.S. Yudkin, S. Klein, and S.W. Coppack. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. Journal of Clinical Endocrinology and Metabolism 82: 4196–4200.
Mota, J.F., W.L. Medina, F. Moreto, and R.C. Burini. 2009. Influence of adiposity on inflammation risk in patients with fasting glucose impairment. Revista de Nutrição 22: 6.
Schmidt, A.M., S.D. Yan, J.L. Wautier, and D. Stern. 1999. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circulation Research 84: 489–497.
Vallerie, S.N., and G.S. Hotamisligil. 2010. The role of JNK proteins in metabolism. Science Translational Medicine 2: 60rv65.
Petersen, A.M., and B.K. Pedersen. 2005. The anti-inflammatory effect of exercise. Journal of Applied Physiology 98: 1154–1162.
Church, T.S., C.P. Earnest, A.M. Thompson, E.L. Priest, R.Q. Rodarte, T. Saunders, R. Ross, and S.N. Blair. 2010. Exercise without weight loss does not reduce C-reactive protein: the INFLAME study. Medicine and Science in Sports and Exercise 42: 708–716.
Jae, S.Y., B. Fernhall, K.S. Heffernan, M. Jeong, E.M. Chun, J. Sung, S.H. Lee, Y.J. Lim, and W.H. Park. 2006. Effects of lifestyle modifications on C-reactive protein: contribution of weight loss and improved aerobic capacity. Metabolism 55: 825–831.
Kelley, G.A., and K.S. Kelley. 2006. Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials. Metabolism 55: 1500–1507.
Handschin, C., and B.M. Spiegelman. 2008. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454: 463–469.
Niu, K., A. Hozawa, S. Kuriyama, K. Ohmori-Matsuda, T. Shimazu, N. Nakaya, K. Fujita, I. Tsuji, and R. Nagatomi. 2006. Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. American Journal of Clinical Nutrition 84: 223–229.
Esmaillzadeh, A., M. Kimiagar, Y. Mehrabi, L. Azadbakht, F.B. Hu, and W.C. Willett. 2006. Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. American Journal of Clinical Nutrition 84: 1489–1497.
de Oliveira Otto, M.C., A. Alonso, D.H. Lee, G.L. Delclos, N.S. Jenny, R. Jiang, J.A. Lima, E. Symanski, D.R. Jacobs Jr., and J.A. Nettleton. 2011. Dietary micronutrient intakes are associated with markers of inflammation but not with markers of subclinical atherosclerosis. Journal of Nutrition 141: 1508–1515.
Takahashi, M.M., E.P. de Oliveira, F. Moreto, K.C. Portero-McLellan, and R.C. Burini. 2010. Association of dyslipidemia with intakes of fruit and vegetables and the body fat content of adults clinically selected for a lifestyle modification program. Archivos Latinoamericanos de Nutricion 60: 148–154.
Mecca, M.S., F. Moreto, F.H. Burini, R.C. Dalanesi, K.C. McLellan, and R.C. Burini. 2012. Ten-week lifestyle changing program reduces several indicators for metabolic syndrome in overweight adults. Diabetology and Metabolic Syndrome 4: 1.
ACKNOWLEDGMENTS
We thank the Grupo de Apoio à Pesquisa (Research Support Group) of the Botucatu School of Medicine for the English language review of the manuscript. We also thank Dr. José Eduardo Corrente for the statistical analysis. Financial support for this study came from CAPES, CNPq, and FUNDAP.
Conflict of Interest
This study has no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moreto, F., de Oliveira, E.P., Manda, R.M. et al. Pathological and Behavioral Risk Factors for Higher Serum C-Reactive Protein Concentrations in Free-Living Adults—a Brazilian Community-Based Study. Inflammation 36, 15–25 (2013). https://doi.org/10.1007/s10753-012-9515-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-012-9515-9